T1	PROC 44 73	Estudio abierto de dos grupos
T2	CHEM 87 100	rilzabrutinib
T3	LIVB 104 113	pacientes
#1	AnnotatorNotes T3	C0030705; Patients; Patient or Disabled Group
T4	DISO 118 152	enfermedad relacionada con la IgG4
T5	PROC 173 217	Estudio de fase IIa, abierto y de dos grupos
T6	CHEM 244 257	rilzabrutinib
T7	DISO 318 328	enfermedad
#2	AnnotatorNotes T7	C0012634; Disease; Disease or Syndrome | C0221423; Illness (finding); Sign or Symptom
T8	LIVB 332 341	pacientes
#3	AnnotatorNotes T8	C0030705; Patients; Patient or Disabled Group
T9	DISO 346 380	enfermedad relacionada con la IgG4
T10	CHEM 433 451	inmunoglobulina G4
#4	AnnotatorNotes T10	C0020860; Immunoglobulin IgG4; Amino Acid, Peptide, or Protein · Immunologic Factor
T11	LIVB 543 549	hombre
#5	AnnotatorNotes T11	C0025266; Male population group; Population Group | C0086418; Homo sapiens; Human
T12	LIVB 552 557	mujer
#6	AnnotatorNotes T12	C0043210; Woman; Population Group | C0242665; wife; Family Group
T13	Age 567 575	≥18 años
T14	PROC 589 608	diagnóstico clínico
#7	AnnotatorNotes T14	C0332140; Diagnosis, clinical; Finding
T15	DISO 612 619	IgG4-RD
T16	PROC 642 661	disminuir una dosis
T17	Dose 652 661	una dosis
T18	CHEM 677 687	prednisona
#8	AnnotatorNotes T18	C0032952; prednisone; Hormone · Organic Chemical · Pharmacologic Substance
T19	Dose 694 702	20-40 mg
T20	Frequency 702 706	/día
T21	Duration 710 719	2 semanas
T22	Date 748 759	Actualmente
T23	Duration 772 783	los 6 meses
T24	CHEM 819 828	rituximab
#9	AnnotatorNotes T24	C0393022; rituximab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T25	ANAT 860 869	células B
#10	AnnotatorNotes T25	C0004561; B-Lymphocytes; Cell
T26	CHEM 872 891	agentes alquilantes
#11	AnnotatorNotes T26	C0002073; Alkylating Agents; Hazardous or Poisonous Substance · Pharmacologic Substance
T27	ANAT 1010 1017	células
#12	AnnotatorNotes T27	C0007634; Cells; Cell | C1269647; Entire cell; Cell
T28	PROC 1042 1061	citometría de flujo
#13	AnnotatorNotes T28	C0016263; Flow Cytometry; Laboratory Procedure
T29	PROC 1079 1106	trasplante de órgano sólido
T30	PROC 1125 1144	prueba de detección
T31	DISO 1148 1151	VIH
#14	AnnotatorNotes T31	C0458074; Human immunodeficiency virus (HIV) status; Finding
T32	DISO 1153 1164	hepatitis B
#15	AnnotatorNotes T32	C0019163; Hepatitis B; Disease or Syndrome
T33	DISO 1166 1177	hepatitis C
#16	AnnotatorNotes T33	C0019196; Hepatitis C; Disease or Syndrome
T34	DISO 1180 1182	TB
#17	AnnotatorNotes T34	C0005586; Bipolar Disorder; Mental or Behavioral Dysfunction | C0040586; Tracheobronchitis; Disease or Syndrome | C0041296; Tuberculosis; Disease or Syndrome
T35	LIVB 1186 1193	Mujeres
#18	AnnotatorNotes T35	C0043210; Woman; Population Group | C0242665; wife; Family Group
T36	PHYS 1218 1229	amamantando
#19	AnnotatorNotes T36	C0006147; Breast Feeding; Organism Function
T37	DISO 476 510	Enfermedad relacionada con la IgG4
T38	CHEM 148 152	IgG4
T39	CHEM 376 380	IgG4
T40	DISO 403 451	Enfermedad relacionada con la inmunoglobulina G4
T41	CHEM 506 510	IgG4
T42	PHYS 1204 1215	embarazadas
T43	CHEM 836 843	agentes
T44	CHEM 259 266	PRN1008
T45	CHEM 267 276	SAR444671
T46	Observation 234 240	efecto
T47	Result_or_Value 1008 1031	5 células por mm cúbico
T48	Result_or_Value 1110 1118	Positivo
T49	Patient 104 113	pacientes
T50	Patient 332 341	pacientes
T51	Patient 543 549	hombre
T52	Patient 552 557	mujer
T53	History_of 1079 1106	trasplante de órgano sólido
T54	Patient 1186 1193	Mujeres
